Our Science
Disruptive Science, New Therapeutic Possibilities
At Endeavor BioMedicines, we believe the greatest medical challenges demand more than incremental improvements; they require bold solutions that unlock the possibility of truly disruptive and positive change.
Endeavor’s first two investigational candidates, ENV-101 and ENV-501, offer novel approaches to potentially disrupt the underlying mechanisms that cause serious diseases.
